Nortis Home                 Page


NEWS & EVENTS

  • January 2014: Nortis is awarded pilot study funding from the PATH Malaria Vaccine Initiative (MVI).
  • September 2013: Nortis is awarded NIH/NCI, SBIR contract for developing a brain metastasis assay for drug screening.
  • August 2013: Nortis is awarded funding by the PATH Malaria Vaccine Initiative (MVI) to develop a platform for testing transmission blocking vaccines.
  • November 2012: Nortis is awarded a grant from the Bill & Melinda Gates Foundation to develop a chip for testing anti-malaria drugs.

 

 

Nortis               Index
Technology Applications About Us Contact Us Home Page